Hormones and Growth factors signalling Section Editor - Gajanan V. Sherbet ( gajanan.sherbet@newcastle.ac.uk )

Deep Insight Adiponectin and cancer The contribution of circadian rhythms to cancer formation and mortality Class III beta-tubulin, drug resistance and therapeutic approaches in cancers Does DNA ploidy and synthesis phase dynamic accentuate the predictive power of oestrogen and progesterone receptors in breast cancer progression and prognosis? Tissue specific role of calcium sensing receptor Genes specifically involved in Hormones and Growth factors signalling ALDH1A1 (Aldehyde Dehydrogenase 1 family member A1) 2019-04 FOXE1 (forkhead box E1 (thyroid transcription factor 2)) 2010-05 GHRL (ghrelin/obestatin prepropeptide) 2001-03 IGF1R (insulin-like growth factor 1 receptor) 2008-09 LIPE (lipase E, hormone sensitive type) 2018-02 NCOA1 (Nuclear receptor coactivator 1) 2018-02 NPY (neuropeptide Y) 2009-05 NR0B1 (nuclear receptor subfamily 0, group B, member 1) 2013-11 PGR (progesterone receptor) 2017-02 PRLR (prolactin receptor) 2011-12 PTHLH (parathyroid hormone-like hormone) 2012-07 UBE3A (ubiquitin protein ligase E3A) 2008-11 VIP (vasoactive intestinal peptide) 2013-08 Other Genes involved in Hormones and Growth factors signalling FAP (fibroblast activation protein alpha)

Iconography Figure from The_contribution_of_circadian_rhythms_to_cancer_formation_and_mortality

Contributor(s)

Written	Oct 2009	Jean-Loup Huret
Updated	Oct 2020	Jean-Loup Huret and Philippe Dessen

Citation

This paper should be referenced as such :

, Huret JL, Dessen P.. Hormone_system. Atlas Genet Cytogenet Oncol Haematol. Oct 2020 . URL : http://AtlasGeneticsOncology.org/Categories/Hormone_system.html